{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T03:35:08Z","timestamp":1773804908087,"version":"3.50.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100000780","name":"European Union","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"crossref"}]},{"name":"National Funds"},{"name":"QREN"},{"name":"FCT","award":["SFRH\/BPD\/81963\/2011"],"award-info":[{"award-number":["SFRH\/BPD\/81963\/2011"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Pharmaceutics"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1016\/j.ijpharm.2014.10.067","type":"journal-article","created":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T16:31:53Z","timestamp":1414859513000},"page":"519-526","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":101,"title":["A new topical formulation for psoriasis: Development of methotrexate-loaded nanostructured lipid carriers"],"prefix":"10.1016","volume":"477","author":[{"given":"Maria Filipa","family":"Pinto","sequence":"first","affiliation":[]},{"given":"Catarina Costa","family":"Moura","sequence":"additional","affiliation":[]},{"given":"Cl\u00e1udia","family":"Nunes","sequence":"additional","affiliation":[]},{"given":"Marcela A.","family":"Segundo","sequence":"additional","affiliation":[]},{"given":"Sofia A.","family":"Costa Lima","sequence":"additional","affiliation":[]},{"given":"Salette","family":"Reis","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/j.ijpharm.2014.10.067_bib0005","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ijpharm.2010.09.007","article-title":"Development, evaluation and clinical studies of Acitretin loaded nanostructured lipid carriers for topical treatment of psoriasis","volume":"401","author":"Agrawal","year":"2010","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2014.10.067_bib0010","first-page":"1","article-title":"Capsaicin delivery into the skin with lipidic nanoparticles for the treatment of psoriasis","author":"Agrawal","year":"2013","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"key":"10.1016\/j.ijpharm.2014.10.067_bib0015","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1111\/j.1365-4632.2011.04913.x","article-title":"Novel stain-free lecithinized coal tar formulation for psoriasis","volume":"50","author":"Bhatia","year":"2011","journal-title":"Int. J. Dermatol."},{"key":"10.1016\/j.ijpharm.2014.10.067_bib0020","doi-asserted-by":"crossref","first-page":"J314","DOI":"10.1016\/j.jaut.2009.12.001","article-title":"Geoepidemiology and environmental factors of psoriasis and psoriatic arthritis","volume":"34","author":"Chandran","year":"2010","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.ijpharm.2014.10.067_bib0025","first-page":"1","article-title":"Lifting the silver flakes: the pathogenesis and management of chronic plaque psoriasis","volume":"21","author":"Chong","year":"2013","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.ijpharm.2014.10.067_bib0030","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1208\/s12249-010-9563-0","article-title":"Recent advances in lipid nanoparticle formulations with solid matrix for oral drug delivery","volume":"12","author":"Das","year":"2011","journal-title":"AAPS Pharm. Sci. Tech."},{"key":"10.1016\/j.ijpharm.2014.10.067_bib0035","doi-asserted-by":"crossref","first-page":"247","DOI":"10.3109\/09687688.2010.522203","article-title":"Interaction of nanoparticles and cell-penetrating peptides with skin for transdermal drug delivery","volume":"27","author":"Desai","year":"2010","journal-title":"Mol. Membr. Biol."},{"key":"10.1016\/j.ijpharm.2014.10.067_bib0040","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.colsurfb.2010.07.029","article-title":"Design and ocular tolerance of flurbiprofen loaded ultrasound-engineered NLC","volume":"81","author":"Gonzalez-Mira","year":"2010","journal-title":"Colloids Surf. B"},{"key":"10.1016\/j.ijpharm.2014.10.067_bib0045","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1517\/17425247.2012.686490","article-title":"Nanocarrier-based topical drug delivery for the treatment of skin diseases","volume":"9","author":"Gupta","year":"2012","journal-title":"Exp. Opin. Drug. Deliv."},{"key":"10.1016\/j.ijpharm.2014.10.067_bib0050","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1468-3083.2009.03358.x","article-title":"Topical corticosteroids in psoriasis: strategies for improving safety","volume":"24","author":"Horn","year":"2010","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"10.1016\/j.ijpharm.2014.10.067_bib0055","doi-asserted-by":"crossref","first-page":"261","DOI":"10.3109\/09546634.2011.643219","article-title":"Oral vitamin D, still a viable treatment option for psoriasis","volume":"24","author":"Kamangar","year":"2013","journal-title":"J. Dermatolog. Treat."},{"key":"10.1016\/j.ijpharm.2014.10.067_bib0060","doi-asserted-by":"crossref","first-page":"8858","DOI":"10.1021\/la0503451","article-title":"Methotrexate-modified superparamagnetic nanoparticles and their intracellular uptake into human cancer cells","volume":"21","author":"Kohler","year":"2005","journal-title":"Langmuir"},{"key":"10.1016\/j.ijpharm.2014.10.067_bib0065","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ijpharm.2003.10.038","article-title":"Potential use of nanoparticles for transcutaneous vaccine delivery: effect of particle size and charge","volume":"275","author":"Kohli","year":"2004","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2014.10.067_bib0070","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1016\/j.msec.2013.01.037","article-title":"High melting lipid based approach for drug delivery: solid lipid nanoparticles","volume":"33","author":"Kumar","year":"2013","journal-title":"Mater Sci. Eng. C"},{"key":"10.1016\/j.ijpharm.2014.10.067_bib0075","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.2165\/11634980-000000000-00000","article-title":"Current and emerging systemic treatment strategies for psoriasis","volume":"72","author":"Laws","year":"2012","journal-title":"Drugs"},{"key":"10.1016\/j.ijpharm.2014.10.067_bib0080","first-page":"117","article-title":"Combination of calcipotriol and methotrexate in nanostructured lipid carriers for topical delivery","volume":"5","author":"Lin","year":"2010","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.ijpharm.2014.10.067_bib0085","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1016\/j.amjcard.2011.06.054","article-title":"Systematic review and meta-analysis of methotrexate use and risk of cardiovascular disease","volume":"108","author":"Micha","year":"2011","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ijpharm.2014.10.067_bib0090","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1517\/17425247.2010.503953","article-title":"Topical delivery for the treatment of psoriasis","volume":"7","author":"Mitra","year":"2010","journal-title":"Exp. Opin. Drug Deliv."},{"key":"10.1016\/j.ijpharm.2014.10.067_bib0095","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.ijpharm.2011.05.008","article-title":"Lipid nanocarriers for dermal delivery of lutein: preparation characterization, stability and performance","volume":"414","author":"Mitri","year":"2011","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2014.10.067_bib0100","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1468-3083.2011.03991.x","article-title":"Methotrexate in psoriasis: a systematic review of treatment modalities, incidence, risk factors and monitoring of liver toxicity","volume":"25","author":"Montaudi\u00e9","year":"2011","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"10.1016\/j.ijpharm.2014.10.067_bib0105","article-title":"Co-association of methotrexate and SPIONs into anti-CD64 antibody-conjugated PLGA nanoparticles for a theranostic application","volume":"9","author":"Moura","year":"2014","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.ijpharm.2014.10.067_bib0110","doi-asserted-by":"crossref","first-page":"S131","DOI":"10.1016\/S0169-409X(02)00118-7","article-title":"Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations","volume":"54","author":"Muller","year":"2002","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijpharm.2014.10.067_bib0115","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1468-3083.2011.04059.x","article-title":"In touch with psoriasis: topical treatments and current guidelines","volume":"25","author":"Murphy","year":"2011","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"10.1016\/j.ijpharm.2014.10.067_bib0120","series-title":"Psoriasis, a systemic disease beyond the skin, as evidenced by psoriatic arthritis and many comorbities\u2013clinical remission with a Leishmania amastigotes vaccine, a serendipity finding","author":"O\u2019Daly","year":"2011"},{"key":"10.1016\/j.ijpharm.2014.10.067_bib0125","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s00403-011-1163-7","article-title":"Nanoparticles in dermatology","volume":"303","author":"Papakostas","year":"2011","journal-title":"Arch. Dermatol. Res."},{"key":"10.1016\/j.ijpharm.2014.10.067_bib0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1468-3083.2012.04518.x","article-title":"Evidence-based recommendations on topical treatment and phototherapy of psoriasis: systematic review and expert opinion of a panel of dermatologists","volume":"26","author":"Paul","year":"2012","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"10.1016\/j.ijpharm.2014.10.067_bib0135","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.jconrel.2013.05.020","article-title":"Novel colloidal carriers for psoriasis: current issues, mechanistic insight and novel delivery approaches","volume":"170","author":"Pradhan","year":"2013","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2014.10.067_bib0140","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.addr.2011.01.012","article-title":"Nanoparticles and microparticles for skin drug delivery","volume":"63","author":"Prow","year":"2011","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijpharm.2014.10.067_bib0145","doi-asserted-by":"crossref","first-page":"6888","DOI":"10.1166\/jnn.2013.7766","article-title":"Optimization of curcumin loaded lipid nanoparticles formulated using high shear homogenization (HSH) and ultrasonication (US) methods","volume":"13","author":"Puglia","year":"2013","journal-title":"J. Nanosci. Nanotechnol."},{"key":"10.1016\/j.ijpharm.2014.10.067_bib0150","doi-asserted-by":"crossref","first-page":"287","DOI":"10.2174\/187153012802002901","article-title":"Classical to current approach for treatment of psoriasis: a review","volume":"12","author":"Rahman","year":"2012","journal-title":"Endocr. Metab. Immune. Disord. Drug Targets"},{"key":"10.1016\/j.ijpharm.2014.10.067_bib0155","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.2165\/11591580-000000000-00000","article-title":"The burden of moderate to severe psoriasis","volume":"30","author":"Raho","year":"2012","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.ijpharm.2014.10.067_bib0160","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ijpharm.2013.08.019","article-title":"Nano-lipoidal carriers of tretinoin with enhanced percutaneous absorption, photostability, biocompatibility and anti-psoriatic activity","volume":"456","author":"Raza","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2014.10.067_bib0165","doi-asserted-by":"crossref","first-page":"e13","DOI":"10.1111\/j.1600-0846.2011.00601.x","article-title":"Emerging applications of nanomedicine in dermatology","volume":"19","author":"Saraceno","year":"2013","journal-title":"Skin Res. Technol."},{"key":"10.1016\/j.ijpharm.2014.10.067_bib0170","first-page":"393","article-title":"Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) \u2013 structural investigations on two different carrier systems","volume":"15","author":"Saupe","year":"2005","journal-title":"Biomed. Mater. Eng."},{"key":"10.1016\/j.ijpharm.2014.10.067_bib0175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1440-0960.2011.00839.x","article-title":"The use of methotrexate in dermatology: a review","volume":"53","author":"Shen","year":"2012","journal-title":"Australas. J. Dermatol."},{"key":"10.1016\/j.ijpharm.2014.10.067_bib0180","doi-asserted-by":"crossref","first-page":"41","DOI":"10.2174\/187221013804484827","article-title":"Nanostructured lipid carriers (NLCs) for drug delivery and targeting","volume":"7","author":"Wang","year":"2013","journal-title":"Recent Pat. Nanotechnol."},{"key":"10.1016\/j.ijpharm.2014.10.067_bib0185","doi-asserted-by":"crossref","first-page":"15957","DOI":"10.1039\/c1jm12720a","article-title":"Solid lipid nanoparticles self-assembled from electrosprayed polymer-based microparticles","volume":"21","author":"Yu","year":"2011","journal-title":"J. Mater. Chem."},{"key":"10.1016\/j.ijpharm.2014.10.067_bib0190","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1039\/C0CC03521A","article-title":"Coaxial electrospinning with organic solvent for controlling the size of self-assembled nanoparticles","volume":"47","author":"Yu","year":"2011","journal-title":"Chem. Commun."},{"key":"10.1016\/j.ijpharm.2014.10.067_bib0195","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.2147\/IJN.S45031","article-title":"Preparation, characterization, and in vivo pharmacokinetics of nanostructured lipid carriers loaded with oleanolic acid and gentiopicrin","volume":"8","author":"Zhang","year":"2013","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.ijpharm.2014.10.067_bib0200","first-page":"552","article-title":"Drug release and release mechanism of prednisolone loaded solid lipid nanoparticles","volume":"53","author":"zur Muhlen","year":"2013","journal-title":"Pharmazie"}],"container-title":["International Journal of Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S037851731400790X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S037851731400790X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,12]],"date-time":"2020-05-12T11:51:06Z","timestamp":1589284266000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S037851731400790X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":40,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["S037851731400790X"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpharm.2014.10.067","relation":{},"ISSN":["0378-5173"],"issn-type":[{"value":"0378-5173","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A new topical formulation for psoriasis: Development of methotrexate-loaded nanostructured lipid carriers","name":"articletitle","label":"Article Title"},{"value":"International Journal of Pharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpharm.2014.10.067","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}